i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial

Clinical trial NCT06480500 · RECRUITING

Trial details

NCT number: NCT06480500
Sponsor: University Health Network, Toronto
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder Suicide Treatment Resistant Depression

Start date: 2024-01-02
Primary completion: 2026-03-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.